Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMT2003 in advanced primary hepatocellular carcinoma
NCT00405873Phase 2Terminated
- Sponsor
- Auron Healthcare GmbH
- Start
- Mar 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AMT 2003 in hepatocellular carcinoma (HCC), sponsored by Auron Healthcare GmbH. Started Mar 2007; status: terminated.
02
Drugs
AMT 2003
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00405873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405873.